# Eugene Chan

Suosituimmat podcast-jaksot
Päivitetty:

Creating “future proof” antibodies vs. virus variants like Omicron with Ian Chan, co-founder of Abpro

Today's guest is Ian Chan the co-founder and executive chairman of Abpro. Abpro is improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Ian explains how their technology is "future proofing" antibodies. Recently, Abpro announced its ABP…

Antibodies are the future of cancer treatment

"Since President Nixon declared war on cancer in 1971, and despite some great victories and many losses, there continues to be a never-ending battle in this long-fought war that seems never-ending. The convergence of great intellect and resources of academia and industry, fueled by continued entrep…

The Antibody Engine With Abpro's Chan Brothers

We love to hear from our listeners. Send us a message. In an industry that takes new business naming conventions to extremes, Abpro is a refreshingly clear exception. Brothers Ian Chan (CEO & Co-Founder) and Eugene Chan, M.D., (Chairman & Co-Founder) are antibody pros. The company's pipeline spans…

Platform to Develop Next Generation Antibodies with Two Binding Sites to Treat HER2+ Related Cancer and COVID with Dr. Eugene Chan Abpro TRANSCRIPT

Dr. Eugene Chan, Chairman and Co-Founder of Abpro, talks about the next generation of antibody therapies that can target more than one target to activate the immune system in the fight against cancer. Abpro is also working on a prophylactic antibody therapy to help prevent immunocompromised patien…

Platform to Develop Next Generation Antibodies with Two Binding Sites to Treat HER2+ Related Cancer and COVID with Dr. Eugene Chan Abpro

Dr. Eugene Chan, Chairman and Co-Founder of Abpro, talks about the next generation of antibody therapies that can target more than one target to activate the immune system in the fight against cancer. Abpro is also working on a prophylactic antibody therapy to help prevent immunocompromised patien…

Starting a Drug Manufacturing Venture | Eugene Chan, Abpro

In this episode, I'm joined by Dr. Eugene Chan, a leading figure at the intersection of healthcare and technology. We delve into the profound impacts of artificial intelligence and technological advancements on patient care and the pharmacy sector. Dr. Chan's insights shed light on the future of he…

Breakthroughs in liver cancer treatment

We sit down with health care executive Eugene Chan to explore the rising rates of liver cancer worldwide and the potential game-changer in its treatment: monoclonal antibodies. Join us as we delve into the factors contributing to liver cancer's prevalence, the impact of vaccination, and the promisi…

Cdns Aren’t Happy With Any Of The Fed Party Leaders

The Hamilton Today Podcast with Scott Thompson: The Leafs have fired Head Coach Sheldon Keefe. According to new polling from the Angus Reid Institute, the popularity of federal party leaders in Canada is at its lowest ever. Mark Carney says the carbon tax served a purpose “until now,” suggesting th…

From Space to StartEngine: Revolutionizing Diagnostics with Single-Drop Blood Testing

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work. Watch the show on television by d…

EP278 AI Governance in Higher Ed with Dr. Eugene Chan

Most organizations govern AI the same way cities govern speeding. They set a rule, then punish people who break it. Dr. Eugene Chan thinks that's the least interesting tool available. He's a behavioural scientist - founder of the consultancy Behavieural and Professor of Business at Tyndale Univers…